glp 1 2 or 3 Managing symptoms with GLP-1 receptor agonists and lifestyle changes GIP and GLP‐1, the two

Constipation: Some patients experience constipation, which can be managed through dietary adjustments and increased fluid intake

GLP-1 medications require ongoing use to prevent regaining up to two-thirds of the lost weight

Further exploration of these modified agents in animal models of cardiometabolic diseases will deepen our understanding of the potential cardioprotective mechanisms of GLP-1 and GLP-1RAs and potentially provide future directions for precise therapeutic intervention [180]

This would involve setting a price that considers the orphan drug status typically granted to PWS medications but is also acceptable to healthcare payers